Overview
Total raised
$65M
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 13, 2026 | Boulevard Bio Raises $65M in Funding | Boulevard Bio, a NYC-based precision immunology company, raised $65M in funding. Backers included Deerfield Management and its affiliates. The company intends to use the funds to advance its pipeline of multi-specific antibodies targeting B... |
| Aug 12, 2026 | Venture Capital & Startup Funding Roundup, August 12, 2026: Coatue, Franklin Templeton, CapitalG, Menlo Ventures, Sequoia Capital & More | The day’s deals underscore one clear theme: venture capital continues to pour into fundamental infrastructure and vertical AI playbooks, not consumer fluff. A massive $750M infusion into Form Energy’s iron-air battery plant leads the charge... |
| Aug 12, 2026 | Boulevard Bio Launches with $65 Million | NEW YORK, NY, Boulevard Bio announced its emergence from stealth with $65 million from founding investor Deerfield Management. >> Click here for more funding data on Boulevard Bio >> To export Boulevard Bio funding data to PDF ... |
| Boulevard Bio | “Boulevard Bio develops multi-specific antibodies for B cell-driven autoimmune diseases through precision immunology.” |
Reviews 0
FAQ about Boulevard Bio
How much funding has Boulevard Bio raised?
Boulevard Bio has raised $65M in total across 1 funding round.
What has the press written about Boulevard Bio?
Parsers VC has collected 5 articles mentioning Boulevard Bio, among them “Boulevard Bio Raises $65M in Funding” (Aug 13, 2026) and “Venture Capital & Startup Funding Roundup, August 12, 2026: Coatue, Franklin Templeton, CapitalG, Menlo Ventures, Sequoia Capital & More” (Aug 12, 2026).
Is Boulevard Bio still active?
Yes, Boulevard Bio is active; its latest activity on Parsers VC dates from Aug 16, 2026.